Skip Navigation

Recommendation Video Presentation on Second Line Chemo for Advanced NSCLC

Updated Jan 6, 2010, filed in All Journey Phases, Lung Cancer
One of the core issues in managing advanced NSCLC is second line chemotherapy, which was established as improving survival several years ago. This video presentation provides a brief summary of the work that led to the common use of chemotherapy in previously treated patients. Most typically, this is taxotere (docetaxel) or alimta (pemetrexed), and this presentation describes why we focus most commonly on these chemo agents.